PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1437527
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1437527
Multiomics Market size was valued at USD 2,133.45 Million in 2023, expanding at a CAGR of 14.5% from 2024 to 2032.
A novel method called multiomics combines the data sets from several omic groupings for analysis. The genome, proteome, transcriptome, epigenome, and microbiome are the many omic techniques used in multiomics.
Multiomics Market- Market Dynamics
Increasing interest among researchers in the field of single-cell genomics to propel market demand
Single-cell genomics is attracting a significant amount of researcher attention, according to the Global Multiomics Market. The intriguing potential of single-cell research to reveal complex biological processes with previously unheard-of resolution and depth is the source of this growing enthusiasm. Because the area can explain dynamic cellular processes, unravel cellular heterogeneity, and comprehend complicated chemical interactions at the individual cell level, it is attracting a growing number of researchers. Adopting single-cell genomics in the context of multiomics holds great potential for improving the understanding of diverse biological systems and disease mechanisms, which will propel global efforts in personalized medicine, drug development, and biomarker discovery.
Multiomics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 14.5% over the forecast period (2024-2032)
Based on type segmentation, the PCR segment dominates the market
Based on application segmentation, the clinical diagnostics sector dominates the market
Based on region, North America was the leading revenue generator in 2023
The Global Multiomics Market is segmented based on Product & Services, Type, Platform, Application, End-Use, and Region.
The market is divided into two categories based on type: Bulk Multiomics and Single-cell Multiomics. The Bulk Multiomics segment dominates the market. Bulk multiomics is often required to systematically explain the pathophysiology of disorders and other phenotypes at the individual level. The dominance of this industry can be due to the multiple advantages of bulk multiomics. The straightforward experimental procedure and reasonably priced large-scale sample dissection are two of these benefits. Furthermore, live cells are not necessary for bulk multiomics techniques.
The market is divided into four categories based on application: Neurology, Oncology, Cell Biology and Immunology. The Cell Biology sector dominates the market and is likely to maintain its dominance during the forecast period. Understanding cellular biology in the context of both health and illness is being revolutionized by the integration of multiomics methods. Furthermore, there are a lot of ways to comprehend cell biology. For instance, BioSkryb Genomics unveiled two technologies in February 2023 that enable single-cell multiomic analysis. These products can aid in the multiomic platforms knowledge of cell biology.
Multiomics Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market during the forecast period. The biggest revenue share is supported by the existence of important players in the area. Additionally, businesses are striving aggressively to bolster their presence, which is supporting regional industry. For instance, in February 2023, Actuate Therapeutics and the American company Tempus worked together to identify and further verify biomarker profiles in cancer patients. In this initiative, Tempus is utilizing the multiomics technique to enhance research and increase new scientific understandings. These kinds of tactics are promoting regional growth.
The prominent players operating in the market are QIAGEN, PerkinElmer Inc., Illumina, Inc, Danaher, Thermo Fisher Scientific Inc., Shimadzu Corporation, Bruker, BD, Agilent Technologies, Inc. and BGI. These players perform various strategies to remain competitive in the market including product launch, acquisition, expansion and many others.
In April 2023, in a single, low-volume sample, biomodal, formerly known as Cambridge Epigenetix, unveiled a novel duet multiomics solution that allows the simultaneous phased reading of genetic and epigenetic data.
GLOBAL MULTIOMICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
QIAGEN
PerkinElmer Inc.
Illumina, Inc
Danaher
Thermo Fisher Scientific Inc.
Shimadzu Corporation
Bruker
BD
Agilent Technologies, Inc.
BGI